GoodRx Reports Fourth Quarter and Full Year 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends up on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX)
February 27, 2025 4:05 PM ESTRaymond James analyst Aaron Kessler reiterated a Strong Buy rating and $9.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX).
The analyst comments "All in all, it was a solid quarter, and we expect a more stable cadence of expectations/earnings... More
GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi
February 27, 2025 3:15 PM ESTCiti analyst Daniel Grosslight raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $6.75 (from $6.25) while maintaining a Buy rating.
The analyst comments "After a couple quarters of excess volatility, GDRXs 4Q results should be a bit of a reprieve for... More
